StonvexLoading…
StonvexStonvexStonvexCore line items from GHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $4.91B | $4.79B | $4.41B | $1.11B |
Operating Income | $234.95M | $215.50M | $69.39M | $-57.11M |
Net Income | $292.29M | $724.63M | $205.29M | $-23.03M |
EPS (Diluted) | $66.47 | $163.40 | $43.82 | $-5.02 |
Total Assets | $8.40B | $7.68B | $7.19B | Not available |
Total Liabilities | $3.53B | $3.35B | $3.16B | Not available |
Cash & Equivalents | $266.99M | $260.85M | $169.90M | Not available |
Free Cash Flow OCF − CapEx | $275.30M | $324.08M | $166.43M | Not available |
Shares Outstanding | 4.37M | 4.41M | 4.65M | Not available |